July 1, 2021

2021 AHA-VIVA FOUNDATION RESEARCH AWARDS

The VIVA Foundation is committed to supporting the next generation of vascular scientists. In partnership with the American Heart Association, The Foundation has funded early career researchers since 2017. Their research expands our understanding of cardiovascular disease from a number of perspectives. See the list of 2021 grant recipients below, along with their winning project titles and a list of the resulting publications.

Click here to return to the main article

Shuai Li, MD, PhD | Board of Regents of the University of Nebraska University of Nebraska Medical Center
Project:
Autophagy in Peripheral Artery Disease: Clinical Significance and Therapeutic Potential

  • Ischemic Myopathy in the Leg Muscles of Patients with Peripheral Artery Disease: Autophagy Fails to Respond to the Increased Damage—Journal of Neuropathology & Experimental Neurology, 2023

Brittany Weber, MD | Brigham and Women's Hospital, Inc.
Project:
Advanced CV imaging and immunophenotyping to study coronary vascular health in psoriasis

  • Rheumatoid arthritis and cardiovascular complications during delivery: a United States inpatient analysis—European Heart Journal, 2024
  • Coronary Microvascular Function Following Severe Preeclampsia—Hypertension, 2024
  • Lipoprotein(a): Emerging insights and therapeutics—American Journal of Preventive Cardiology, 2024
  • Comparative Effectiveness of PET and SPECT MPI for Predicting Cardiovascular Events After Kidney Transplant—Circulation: Cardiovascular Imaging, 2024
  • Interplay Between Systemic Inflammation, Myocardial Injury, and Coronary Microvascular Dysfunction in Rheumatoid Arthritis: Results From the LiiRA Study—Journal of the American Heart Association, 2024
  • Multimodality imaging to assess diagnosis and evaluate complications of large vessel arteritis—Journal of Nuclear Cardiology, 2024
  • Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) Registry—Journal of the American Heart Association, 2024
  • Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases: JACC Scientific Statement—Journal of the American College of Cardiology, 2023
  • Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease—Nature Reviews Rheumatology, 2023
  • Acute cardiovascular complications of immune-mediated systemic inflammatory diseases—European Heart Journal: Acute Cardiovascular Care, 2023
  • Atherosclerosis in Systemic Lupus Erythematosus—Current Atherosclerosis Reports, 2023
  • Association Between Inflammation, Incident Heart Failure, and Heart Failure Subtypes in Patients With Rheumatoid Arthritis—Arthritis Care & Research, 2023
  • Pericarditis Management in Individuals Contemplating Pregnancy, Currently Pregnant, or Breastfeeding—Current Cardiology Reports, 2023
  • Advances in Diagnosis and Therapeutics in Recurrent Autoimmune Pericarditis in Pregnancy—JACC: Case Reports, 2023
  • Serological response to vaccination in post-acute sequelae of COVID—BMC Infectious Diseases, 2023
  • Feasibility of Simultaneous Quantification of Myocardial and Renal Perfusion With Cardiac Positron Emission Tomography—Circulation: Cardiovascular Imaging, 2023
  • The “power of zero” CAC validated for absence of ischemia on PET?—Journal of Nuclear Cardiology, 2023
  • Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings—Journal of Psoriasis and Psoriatic Arthritis, 2023
  • Coronary Microcirculatory Dysfunction in People With HIV and Its Association With Antiretroviral Therapy—Journal of the American Heart Association, 2023
  • Feasibility of Simultaneous Quantification of Myocardial and Renal Perfusion With Cardiac Positron Emission Tomography—Circulation: Cardiovascular Imaging, 2023
  • Association Between Systemic Vasculitis and Coronary Microvascular Dysfunction in the Absence of Obstructive Coronary Artery Disease—Circulation: Cardiovascular Imaging, 2023
  • Cardiovascular outcomes in patients with coronary artery disease and elevated lipoprotein(a): implications for the OCEAN(a)-outcomes trial population—European Heart Journal Open, 2023
  • Cardiovascular Implications of Immune Disorders in Women—Circulation Research, 2022
  • The relationship between ASCVD risk, inflammation, and coronary—Journal of the American Heart Association, 2022
  • Psoriasis and Cardiovascular Disease: Novel Mechanisms and EvolvingCurrent Atherosclerosis Reports, 2021